Ignite Creation Date:
2024-05-06 @ 6:40 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05740280
Status:
SUSPENDED
Last Update Posted:
2023-05-26
First Post:
2023-02-05
Brief Title:
iCP-NI - Safety Tolerability Pharmacokinetic and Immunogenicity Study in Healthy Male and Female Subjects
Sponsor:
Cellivery Therapeutics Inc
Organization:
Cellivery Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-19
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-17
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-08-17
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-05
First Submit QC Date:
February 21 2023
Study First Post Date:
2023-02-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-24
Last Update Post Date:
2023-05-26
Last Update Post Date Type:
ACTUAL